microRNA target prediction programs predict many false positives

  1. Hervé Seitz1
  1. 1Institut de Génétique Humaine, CNRS UPR 1142, 34396 Montpellier, France;
  2. 2INSERM, U1183, IRMB, University Hospital St Éloi, 34295 Montpellier, France;
  3. 3University of Medicine, 34060 Montpellier, France;
  4. 4Clinical Department for Osteoarticular Diseases, University Hospital Lapeyronie, 34295 Montpellier, France
  1. Corresponding author: herve.seitz{at}igh.cnrs.fr
  • Present addresses: 5MSU, The Museum of Natural History, Moscow, Russia, 119991; 6Children's Hospital, Boston, MA 02115, USA

Abstract

According to the current view, each microRNA regulates hundreds of genes. Computational tools aim at identifying microRNA targets, usually selecting evolutionarily conserved microRNA binding sites. While the false positive rates have been evaluated for some prediction programs, that information is rarely put forward in studies making use of their predictions. Here, we provide evidence that such predictions are often biologically irrelevant. Focusing on miR-223-guided repression, we observed that it is often smaller than inter-individual variability in gene expression among wild-type mice, suggesting that most predicted targets are functionally insensitive to that microRNA. Furthermore, we found that human haplo-insufficient genes tend to bear the most highly conserved microRNA binding sites. It thus appears that biological functionality of microRNA binding sites depends on the dose-sensitivity of their host gene and that, conversely, it is unlikely that every predicted microRNA target is dose-sensitive enough to be functionally regulated by microRNAs. We also observed that some mRNAs can efficiently titrate microRNAs, providing a reason for microRNA binding site conservation for inefficiently repressed targets. Finally, many conserved microRNA binding sites are conserved in a microRNA-independent fashion: Sequence elements may be conserved for other reasons, while being fortuitously complementary to microRNAs. Collectively, our data suggest that the role of microRNAs in normal and pathological conditions has been overestimated due to the frequent overlooking of false positive rates.

Footnotes

  • Received February 4, 2016.
  • Accepted October 6, 2016.

This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.

| Table of Contents

Preprint Server